In the United States, approximated three million people are affected by peanut or tree nut allergies. Each year in the United …show more content…
Omalizumab is a drug that is used to discontinue the secretion of IgE antibodies that causes the severe allergic reactions ("Xolair (omalizumab)," 2014). This method of treatment is used to lower the level of sensitivity of people have that have severe peanut allergies (Umetsu & Khoriaty, …show more content…
Also the scientists performing this treatment do not test the severity of the patient’s peanut allergy after giving them the drug and prior to giving them the peanuts without the drug. Therefore, people that the drug treatment did not work with would have a severe allergic reaction (Umetsu, Rachid, & Schneider, 2015). Another limitation of these methods of treatment is the amount of success. Though their treatments have been successful, their treatment could be more successful because not everyone was able to handle the treatment and the treatment did not make all of the steps they could have to ensure that most if not all of the antibodies that cause the reaction were